Trupanion(US:TRUP) Financial Modeling Prep·2026-02-12 17:00Core Viewpoint - Trupanion, Inc. is experiencing a potential shift in investor sentiment following a strong earnings report and technical indicators suggesting a trend reversal [2][3][4][5]. Group 1: Company Overview - Trupanion, Inc. is a leading provider of medical insurance for pets, focusing on cats and dogs, and operates in the United States, Canada, Puerto Rico, and Australia [1]. Group 2: Stock Performance and Analyst Sentiment - The consensus price target for Trupanion has decreased from an average of $51.75 to $40 over the past year, indicating increased caution among analysts regarding the stock's performance [2]. - Despite the downward trend in price targets, recent developments, including a hammer chart pattern and upward revisions in earnings estimates, suggest a potential trend reversal [3][6]. - Analyst John Barnidge from Piper Sandler has set a price target of $156 for Trupanion, reflecting a positive outlook for the stock [3][5]. Group 3: Financial Performance - In the Q3 2025 earnings call, Trupanion reported earnings of $0.13 per share, exceeding the Zacks Consensus Estimate of $0.06 per share and showing significant improvement from $0.03 per share in the same quarter last year [4]. - The positive earnings report has contributed to increased investor confidence and an upgrade to a Zacks Rank 1 (Strong Buy) [5][6].